Status: Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
Participants needed: 128
Trial details
Phase: Phase 2Age: 40+Biological sex: AllType: InterventionalSponsor: Cumberland PharmaceuticalsUpdated: Sep 2, 2026Locations: 20
Eligibility criteria
Male or female age 40 years or older [+6]
Relevant airways obstruction (pre-bronchodilator Forced Expiratory Volume in one... [+29]